Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Vertex Pharmaceuticals (VRTX) and Viridian Therapeutics (VRDN)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alphatec Holdings (ATEC – Research Report), Vertex ...
BioSpace10h
Vertex Severs Liver Gene Therapies Partnership with Verve
The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...
Top Biotech Stocks To Follow Today – February 25th
AbbVie, Danaher, Organovo, Thermo Fisher Scientific, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of ...
FierceBiotech17h
Vertex axes Verve gene editing pact amid shift in R&D priorities
Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeuti | Vertex has backed out of its in vivo ...
BioPharma Dive13h
Vertex ends gene editing research pact with Verve
Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited “changing priorities.” ...
ENDPOINTS NEWS13h
Verve is lat­est gene edit­ing com­pa­ny to suf­fer set­back as Ver­tex walks away from pact
Vertex Pharmaceuticals exits liver disease gene editing program with Verve Therapeutics. Verve continues work on a separate ...